Viking Therapeutics Income Statement (2014-2026) | VKTX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.01B0.01B0.02B0.02B0.02B0.02B0.02B0.03B0.04B0.06B0.09B0.15B0.15B
Selling, General & Administrative (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B0.01B0.01B0.01B0.01B0.01B
Operating Expenses (Quarter)
0.02B0.01B0.01B0.02B0.02B0.02B0.02B0.02B0.02B0.03B0.03B0.03B0.03B0.04B0.05B0.06B0.07B0.10B0.16B0.16B
Operating Income (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-0.03B-0.03B-0.04B-0.05B-0.06B-0.07B-0.10B-0.16B-0.16B
EBIT (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-0.03B-0.03B-0.04B-0.05B-0.06B-0.07B-0.10B-0.16B-0.16B
Non-operating items
Non Operating Investment Income (Quarter)
0.00B0.00B0.00B
Interest & Investment Income (Quarter)
-0.00B0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B
Other Non Operating Income (Quarter)
0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Non Operating Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Net income details
EBT (Quarter)
-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.04B-60.35B-49.62B-23.36B-0.09B-0.44B-0.26B-0.29B-0.19B-0.12B-0.15B-0.17B-0.28B-0.27B
Profit After Tax (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.02B-0.02B-0.04B-0.05B-0.07B-0.09B-0.16B-0.16B
Income from Continuing Operations (Quarter)
-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.04B-60.35B-49.62B-23.36B-0.09B-0.44B-0.26B-0.29B-0.19B-0.12B-0.15B-0.17B-0.28B-0.27B
Consolidated Net Income (Quarter)
-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.04B-60.35B-49.62B-23.36B-0.09B-0.44B-0.26B-0.29B-0.19B-0.12B-0.15B-0.17B-0.28B-0.27B
Income towards Parent Company (Quarter)
-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.04B-60.35B-49.62B-23.36B-0.09B-0.44B-0.26B-0.29B-0.19B-0.12B-0.15B-0.17B-0.28B-0.27B
Net Income towards Common Stockholders (Quarter)
-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.04B-60.35B-49.62B-23.36B-0.09B-0.44B-0.26B-0.29B-0.19B-0.12B-0.15B-0.17B-0.28B-0.27B
Additional items
EPS (Basic) (Quarter)
-0.26-0.24-0.20-0.24-0.25-0.23-0.52-768.41-500.21-233.52-0.96-4.21-2.33-2.59-1.74-1.08-1.35-1.54-2.47-2.30
EPS (Diluted) (Quarter)
-0.26-0.24-0.20-0.24-0.25-0.23-0.52-770.20-501.13-233.95-0.97-4.22-2.33-2.60-1.74-1.08-1.35-1.54-2.47-2.30
Shares Outstanding (Quarter)
0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.10B0.10B0.09B0.10B0.11B0.11B0.11B0.11B0.11B0.11B0.11B0.12B
Shares Outstanding (Diluted) (Quarter)
0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.08B0.10B0.10B0.09B0.10B0.11B0.11B0.11B0.11B0.11B0.11B0.11B0.12B
EBITDA (Quarter)
-0.02B-0.01B-0.01B-0.02B-0.02B-0.02B-0.02B-0.02B-0.02B-0.03B-0.03B-0.03B-0.03B-0.04B-0.05B-0.06B-0.07B-0.10B-0.16B-0.16B
Interest Expenses (Quarter)
0.00B0.01B0.00B0.00B0.00B0.00B0.02B60.33B49.59B23.33B0.06B0.40B0.22B0.26B0.14B0.07B0.08B0.07B0.11B0.10B